Comparison the Effect of Cinnarizine and Amitriptyline in Pediatric Migraine
Phase 3
Recruiting
- Conditions
- ?????.Migraine
- Registration Number
- IRCT20191112045413N1
- Lead Sponsor
- Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 70
Inclusion Criteria
Having experienced one or more migraine attacks per month or severe dysfunction in daily and school activities
Exclusion Criteria
Use of prophylactic migraine therapy in at least one previous month
Focal Neurologic Deficit
Known concomitant serious diseases (hepatic, renal, etc)
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Percent of patients who the severity of their headache episodes decreased to less than 50% of baseline. Timepoint: One month before to 3 months after initiation of treatment. Method of measurement: Visual Analogue Scale and Visual Pain Scale.;Percent of patients who the frequency of their headache episodes decreased to less than 50% of baseline. Timepoint: One month before to 3 months after initiation of treatment. Method of measurement: By charting all the headache episodes by detail in the special checklist.;Percent of patients who the duration of their headache episodes decreased to less than 50% of baseline. Timepoint: One month before to 3 months after initiation of treatment. Method of measurement: By charting all the headache episodes by detail in the special checklist.
- Secondary Outcome Measures
Name Time Method Quality of life scoring. Timepoint: One month before to 3 months after initiation of treatment. Method of measurement: PedMIDAS questionnaire.